Fosun Pharma plans Rp60bn Indian arm spin-off
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has filed preliminary IPO documents with India’s securities regulator for a listing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: